Article
Establishment of a CRISPR/Cas9-Mediated Cysltr1 Knockout Mouse Model and iTRAQ-Based Proteomic Analysis.
Proteomics. Clinical applications - 1 May 2018
Mao Junjie, Hu Xiaojun, Pang Pengfei, Zhou Bin, Zhang Yaqin, Li Dan, Shan Hong
Abstract excerpt
PURPOSE: To clarify the role of Cysteinyl leukotrienes receptor type 1 (CYSLTR1) and find the potential predictors of CYSLTR1 antagonists (leukotriene receptor antagonists [LTRAs]) responsiveness in vivo. EXPERIMENTAL DESIGN: Cysltr1 knockout (KO) mouse model is established by the CRISPR/Cas9 system. The phenotype of Cysltr1 KO mice are tested by western blotting (WB), histological examinations, and experiment of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
